New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
Certara2025年12月10日
New Approach Methodologies: Redefining Animal Testing Alternatives
Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…
Certara2025年12月10日
A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs
The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…
Certara2025年11月17日
Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs
Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…
Certara2025年11月12日
Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk
Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…
Danielle Pillsbury2025年11月7日
In silico Safety and Toxicology assessment: ToxStudio®
Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…
Certara2025年10月30日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research
The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…
Danielle Pillsbury2025年9月10日
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…
Certara2025年9月9日
How Pharma Can Transition to Non-animal Studies for Investigational Drugs
Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…
Certara2025年7月25日
